259 related articles for article (PubMed ID: 9280223)
1. Combined modality therapy of non-small cell lung cancer.
Ruckdeschel JC
Semin Oncol; 1997 Aug; 24(4):429-39. PubMed ID: 9280223
[TBL] [Abstract][Full Text] [Related]
2. Multimodality therapy for non-small-cell lung cancer.
Lilenbaum RC; Green MR
Oncology (Williston Park); 1994 May; 8(5):25-31; discussion 32, 35-6. PubMed ID: 8025004
[TBL] [Abstract][Full Text] [Related]
3. [To improve the survival rate of patients suffering from locally advanced non-small cell lung cancer with combination of radiotherapy and chemotherapy].
Zhu GY
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):88-90. PubMed ID: 17445466
[No Abstract] [Full Text] [Related]
4. [What is the value of neoadjuvant therapy in bronchial carcinoma?].
Digel W; Brethner L; Hasse J
Zentralbl Chir; 2000; 125(4):315-8. PubMed ID: 10829310
[TBL] [Abstract][Full Text] [Related]
5. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.
Thomas M; Hoffknecht P; Droege C; Baisch A; Reinmuth N; Kreuter M; Lange T; Berdel WE
Lung Cancer; 2004 Aug; 45 Suppl 2():S99-105. PubMed ID: 15552789
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
Mornex F
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
[No Abstract] [Full Text] [Related]
8. Clinical trials referral resource. Clinical trials in lung cancer.
Feigal EG; Cheson BD; Nelson AP
Oncology (Williston Park); 1997 Nov; 11(11):1686, 1688, 1691, 1694. PubMed ID: 9394366
[No Abstract] [Full Text] [Related]
9. [Is preoperative chemotherapy in locally advanced non-small-cell bronchial carcinoma of value?].
Betticher DC; von Briel C; Gugger M; Cerny T; Ris HB
Ther Umsch; 1998 Jul; 55(7):399-401. PubMed ID: 9702102
[TBL] [Abstract][Full Text] [Related]
10. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
Koukourakis M
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
[No Abstract] [Full Text] [Related]
11. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
[TBL] [Abstract][Full Text] [Related]
12. Multimodality therapy for stage III non-small-cell lung cancer.
Farray D; Mirkovic N; Albain KS
J Clin Oncol; 2005 May; 23(14):3257-69. PubMed ID: 15886313
[TBL] [Abstract][Full Text] [Related]
13. [Recent issues in the treatment of advanced non-small-cell lung cancer].
Negoro S
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1671-9. PubMed ID: 9757191
[TBL] [Abstract][Full Text] [Related]
14. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
[TBL] [Abstract][Full Text] [Related]
15. Failure patterns of combined modality treatment in lung cancer: the impact of staging.
Hoekstra CJ; Rijna H; Smit EF; Van Mourik JC; Postmus PE; Lammertsma AA; Hoekstra OS
Neth J Med; 2002 Mar; 60(1):17-21. PubMed ID: 12074038
[TBL] [Abstract][Full Text] [Related]
16. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
Hoffmann H
Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy for stage III non-small cell lung cancer.
Stinchcombe TE; Fried D; Morris DE; Socinski MA
Oncologist; 2006; 11(7):809-23. PubMed ID: 16880240
[TBL] [Abstract][Full Text] [Related]
18. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
van Meerbeeck JP; Surmont VF
Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
[TBL] [Abstract][Full Text] [Related]
19. The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer.
Belani CP
Clin Lung Cancer; 2005 May; 6(6):331-2. PubMed ID: 15943890
[No Abstract] [Full Text] [Related]
20. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]